Evidence-based medicine

Dr. J. Richard Steadman, Pioneering Orthopaedic Surgeon and Founder of The Steadman Clinic and Steadman Philippon Research Institute, Dies at 85

Retrieved on: 
Sunday, January 22, 2023

That organization exists today as Steadman Philippon Research Institute (SPRI), which is known worldwide for its clinical research database and study of orthopaedic injuries.

Key Points: 
  • That organization exists today as Steadman Philippon Research Institute (SPRI), which is known worldwide for its clinical research database and study of orthopaedic injuries.
  • Combined with the research expertise of SPRI, the clinic will keep the Steadman name at the forefront of sports medicine and groundbreaking research for years to come.
  • Dr. Steadman is survived by his wife, Gay Steadman, son Lyon Steadman, daughter Liddy Lind, and the entire Steadman family and extended family and friends.
  • For further information or other inquiries about The Steadman Clinic or Steadman Philippon Research Institute, contact Lynda Sampson, Vice President of External Affairs ( [email protected] ).

AGFA HealthCare Positioned in the Leaders Category in the IDC MarketScape: U.S. Enterprise Medical Imaging 2022-2023 Vendor Assessment

Retrieved on: 
Wednesday, January 18, 2023

GREENVILLE, S.C., Jan. 18, 2023 (GLOBE NEWSWIRE) -- AGFA HealthCare is proud to announce that it has been named to the Leaders Category in the IDC MarketScape: U.S. Enterprise Medical Imaging 2022-2023 Vendor Assessment (doc #US48168021e, November 2022).

Key Points: 
  • GREENVILLE, S.C., Jan. 18, 2023 (GLOBE NEWSWIRE) -- AGFA HealthCare is proud to announce that it has been named to the Leaders Category in the IDC MarketScape: U.S. Enterprise Medical Imaging 2022-2023 Vendor Assessment (doc #US48168021e, November 2022).
  • According to the IDC MarketScape report, vendors should:
    AGFA HealthCare has been recognized by the IDC MarketScape for the following strengths:
    Enterprise Imaging Platform builds on AGFA's long-standing domain experience in medical imaging IT.
  • The solution combines connected (cross) enterprise care, converged multispecialty support, an adaptable automated workflow, and disease-oriented augmented intelligence across the platform.
  • One customer said, "I took a trip a few times to RSNA and HIMSS, and AGFA was the only vendor at the time that seemed to understand the concept of enterprise imaging."

knownwell Launches with Funding Led by Flare Capital Partners to Change the Shape of Healthcare

Retrieved on: 
Thursday, January 19, 2023

knownwell, the new weight-inclusive healthcare company, today announced it has launched and closed on a $4.5M seed funding round led by Flare Capital Partners.

Key Points: 
  • knownwell, the new weight-inclusive healthcare company, today announced it has launched and closed on a $4.5M seed funding round led by Flare Capital Partners.
  • knownwell is on a mission to disrupt the healthcare industry by providing comprehensive, empathetic health care - at any size.
  • knownwell recognizes and solves this problem by providing full-coverage and tailor-made care to patients without prejudice.
  • “We are thrilled to partner with knownwell, which we believe will fundamentally change how historically underserved patients with metabolic health needs receive healthcare across the country,” said Ian Chiang, Partner at Flare Capital Partners.

Woebot Health Names Trina Histon Vice President of Clinical Product Strategy

Retrieved on: 
Wednesday, January 11, 2023

Woebot Health today announced that it has appointed Trina Histon, PhD, as its Vice President of Clinical Product Strategy.

Key Points: 
  • Woebot Health today announced that it has appointed Trina Histon, PhD, as its Vice President of Clinical Product Strategy.
  • In the newly-created position, Histon will accelerate Woebot’s capabilities to integrate into care pathways and advance the software transformation of psychiatry, behavioral health and primary care.
  • View the full release here: https://www.businesswire.com/news/home/20230111005611/en/
    Trina Histon, PhD, Vice President of Clinical Product Strategy, Woebot Health (Photo: Business Wire)
    Histon’s expertise in embedding and deploying digital health solutions in care delivery spans more than two decades.
  • Before joining Woebot Health, Histon was a Senior Principal Consultant in Kaiser Permanente’s Care Management Institute (CMI).

LifeNet Air Selects Air Methods Ascend for Advanced Clinical Education

Retrieved on: 
Wednesday, January 11, 2023

DENVER, Jan. 11, 2023 /PRNewswire/ -- Air Methods, the nation's leading air medical service provider, announced today that LifeNet Air, a not-for-profit air ambulance company serving Arkansas, Oklahoma and Texas, is making the Ascend critical care clinician education program available to all of its flight crew members to advance their skills in patient care and increase retention of qualified clinicians.

Key Points: 
  • "Having LifeNet flight crew members participate in our Ascend clinician education programs is an exciting extension of our long-standing partnership," said Dr. Stephanie Queen, Air Methods Senior Vice President of Clinical Services.
  • "Equipping air medical personnel with advanced, high-quality education helps build confidence and clinical autonomy, alleviate clinician burnout and improve retention – all vitally important to delivering the best care possible to the emergent patients they serve."
  • "LifeNet has been in partnership with Air Methods for nearly 40 years, and we're excited to provide this additional resource for our team."
  • Started as Air Life by CHRISTUS St. Michael hospital in 1983, the LifeNet Air medical program is the oldest operating helicopter EMS program in the state of Arkansas.

Patient Safety Org Says it is Time to Review New Evidence for FDA-Approved Weight Loss Drugs

Retrieved on: 
Tuesday, January 10, 2023

PLYMOUTH MEETING, Pa., Jan. 10, 2023 /PRNewswire/ -- With rates of obesity and diabetes at record highs, the nation's largest nonprofit patient safety organization is calling on healthcare leaders to change their approach and fully embrace FDA-approved weight-loss drugs. A report from independent nonprofit ECRI outlines a series of myths about weight-loss medication—such as their perceived inconsequence for losing weight and long-term ineffectiveness for keeping it off—that have led to them being dramatically underused. A large body of evidence shows that these drugs are beneficial as an adjunct to diet, exercise, and counseling and should be considered for first-line treatment in many patients, says ECRI.

Key Points: 
  • "Obesity is epidemic and we need comprehensive evidence-based solutions," says Marcus Schabacker, MD, PhD, president and chief executive officer of ECRI.
  • "Millions of people in America resolve to live healthier lives in 2023, possibly including weight loss among their goals," says Schabacker.
  • "Physicians must set aside the misinformation about weight-loss drugs, and personal biases about whether and how people can recover from obesity.
  • NOTE: ECRI received no funding from manufacturers of weight-loss drugs in preparing this independent research assessment.

Duke Health Joins with nference to Advance Medical Research and Patient Care

Retrieved on: 
Wednesday, January 4, 2023

Duke Health is building upon its longstanding history of innovative research by joining with nference, a science-first software company, to transform healthcare by making biomedical knowledge computable.

Key Points: 
  • Duke Health is building upon its longstanding history of innovative research by joining with nference, a science-first software company, to transform healthcare by making biomedical knowledge computable.
  • View the full release here: https://www.businesswire.com/news/home/20230104005064/en/
    “As an academic health system, Duke Health’s mission is to advance the health of our community through innovation and the rapid translation of groundbreaking research,” said A. Eugene Washington, M.D., chancellor for health affairs at Duke and president and CEO of Duke University Health System.
  • “Duke is uniquely positioned to lead efforts in the discovery of new models for care, education, research, and innovation,” said Mary Klotman, M.D., Dean, Duke University School of Medicine, and Vice Chancellor for Health Affairs at Duke.
  • “Duke’s world-class faculty, supported by industry-leading technology, can expand research to further address our community’s most pressing health concerns and to eliminate health inequalities.”
    The collaboration between Duke and nference will evolve and grow over the coming years providing the advanced tools needed to modernize research and improve patient care.

The Society of Neuroplastic Surgery celebrates unprecedented success at 7th Annual Symposium

Retrieved on: 
Tuesday, December 20, 2022

The Society of Neuroplastic Surgery, a non-profit organization dedicated to advancing the art, science, and technology surrounding the new, burgeoning field of neuroplastic and reconstructive surgery, was originally founded in 2018 in Baltimore, Maryland.

Key Points: 
  • The Society of Neuroplastic Surgery, a non-profit organization dedicated to advancing the art, science, and technology surrounding the new, burgeoning field of neuroplastic and reconstructive surgery, was originally founded in 2018 in Baltimore, Maryland.
  • Of note, given the unprecedented success this past weekend, the Society of Neuroplastic Surgery has already begun to schedule and coordinate its Eighth Annual Symposium for late 2023.
  • About The Society of Neuroplastic Surgery:
    Originally founded in 2018 in Baltimore, Maryland, the Society of Neuroplastic Surgery (SNPS) is dedicated to fostering patient care, education, and research in the new burgeoning field [ www.SNPS2018.org ].
  • Through its multidisciplinary collaborations and unique member support, the Society aims to advance the art, science, and technology surrounding Neuroplastic and Reconstructive Surgery.

Bioventus Files for Extension to File Form 10-Q for the Period Ended October 1, 2022

Retrieved on: 
Wednesday, November 16, 2022

In addition, Bioventus is seeking resolution related to the validity of a revised invoice received subsequent to the Company's Q3 Earnings Release.

Key Points: 
  • In addition, Bioventus is seeking resolution related to the validity of a revised invoice received subsequent to the Company's Q3 Earnings Release.
  • As a result of the foregoing, the Companys management has concluded that its internal controls related to the timely recognition of quarterly rebates were inadequate specifically for the period ended October 1, 2022.
  • As permitted by the Form 12b-25 filing, the Company expects to file its Form 10-Q for the period ended October 1, 2022, by November 21, 2022.
  • Bioventus and the Bioventus logo are registered trademarks of Bioventus LLC.

Atropos Health Wins Prestigious UCSF Rising Star Award

Retrieved on: 
Tuesday, November 15, 2022

PALO ALTO, Calif., Nov. 15, 2022 /PRNewswire/ -- Atropos Health, the leader in delivering real-world evidence at the point and pace of care, was named a Rising Star in the Clinical Diagnostic Tool category by the 2022 UCSF Digital Health Awards, awarded to organizations solving healthcare's biggest challenges. 

Key Points: 
  • The UCSF Digital Health Awards is one of the leading awards in the health tech space, with each entrant's products and solutions judged by a UCSF Health Hub panel dedicated to spotlighting technology that is genuinely improving healthcare.
  • Atropos Health evolved from a 2019 Stanford Health Care research project that successfully provided accurate clinical informatics consults in record time.
  • "UCSF has a reputation for being one of the most prestigious awards in health tech, and being named a Rising Star is a great honor for us," says Brigham Hyde, Ph.D., Co-Founder and CEO of Atropos Health.
  • Atropos Health was one of eight finalists in the Rising Star category, with the awards receiving over a thousand submissions.